gdawod1 Profile Banner
Giana Dawod, MD Profile
Giana Dawod, MD

@gdawod1

Followers
3K
Following
7K
Media
139
Statuses
2K

@StrokeMiami fellow by way of @WCMCNeurology | @SVINjournal Digital Strategy | @SVINsociety SoME Vice Chair | 🇯🇴 | Searching for the best ☕️ | Tweets = my own

Joined March 2020
Don't wanna be here? Send us removal request.
@gdawod1
Giana Dawod, MD
3 years
1/ CTA. DSA. MRA. CFD. VWI. So many letters, so many ❓❓❓ & so the discussion ensues - which imaging are YOU going to use for intracranial aneurysm dx + mgt?   Luckily, Beaman et. al go thru +/- of imaging modalities - both old + new🧠   Let's begin! 👇
4
22
70
@svinsociety
SVIN
2 days
🎉 Congratulations to @AmerMalikMD recipient of the 2025 Distinguished Service Award! This honor recognizes outstanding leadership, dedication, and service to the SVIN community. Learn more: https://t.co/0MB8xBLGYt #SVIN #SVIN25 #SVINAnnualMeeting #SVINAwards
0
8
17
@DevinZarkowsky
Devin Zarkowsky
1 day
Wow. A totally unexpected result. Likely the end of CEA for ACAS.
@NEJM
NEJM
2 days
Presented at #SVIN25: CREST-2: In high-grade asymptomatic carotid stenosis, addition of stenting to medical therapy led to a lower risk of stroke over a 4-year period. Endarterectomy did not lead to a significant benefit. Full results: https://t.co/ZHLCV9ukNU Editorial:
9
14
105
@AmolMehtaMD
Amol Mehta, MD
2 days
Huge news!! Bottom line - CAS shown to help prevent primary event in asymptomatic 70%+ stenosis compared to MM. #svin2025 Medical Management and Revascularization for Asymptomatic Carotid Stenosis | New England Journal of Medicine
Tweet card summary image
nejm.org
Improvements in medical therapy, carotid-artery stenting, and carotid endarterectomy call into question the preferred management of asymptomatic carotid stenosis. Whether adding revascularization t...
0
6
23
@SitaraKoneru
Sitara Koneru, MD
1 day
🚨LIVE from today’s plenary session! #SVIN25 @FazalZaidi9 presents the results of RESTORE 📍high rates of successful navigation to clot 📍high rates of revasc 📍high FPE #SVIN25 @svinsociety @SVINJournal @YoungNIR @ESOstroke @MThrombectomy @WomenInNeuroIR @StrokeAHA_ASA
0
9
14
@aemaz100
Muhammad Aemaz Ur Rehman
2 days
Landmark CREST-2 trial just released at #SVIN25. The trial is positive!! Benefit of CAS+MM over MM alone in asymptomatic high grade carotid stenosis. More importantly, no benefit seen for CEA+MM compared to MM alone. Exciting times ahead!
1
7
11
@almuftifawaz
Fawaz Al-Mufti, MD, FSVIN
2 days
Verdict is out!!!!! #CREST2 RESULTS FAVORING CAS!!! Absolute risk difference = 3.2% (95% Cl, 0.6 to 5.9; P=0.016) Relative risk = 2.13 (95% Cl, 1.15 to 4.39) Happening now at #SVIN25 @svinsociety @MThrombectomy
0
52
146
@gdawod1
Giana Dawod, MD
1 day
A prolific day for the fields of #Vascular & #Interventional #Neurology here at @svinsociety #SVIN25 #CREST2 Results 🚨 CAS + IMM > IMM alone, lower risk of periop stroke/death within 4y for asymptomatic high grade carotid stenosis, no sig benefit in CEA arm
3
10
44
@neurona_critica
Mica Schachter, MD
2 days
#SVIN25 session: World Interventional Neuroscience (WIN). Advances in stroke care from Egypt, Chile, Vietnam, Ethiopia, Armenia, and West Africa @svinsociety @MThrombectomy
1
3
11
@StrokeAHA_ASA
Stroke AHA/ASA
12 days
In an individual participant data meta-analysis of RCTs, acute carotid stenting during EVT was associated with better functional outcomes than delayed carotid stenting, and prior IVT treatment did not modify this. #stroke https://t.co/C070RGGi4t
2
25
56
@catton_md
Raymond Catton, MD
2 days
AI in Stroke 🧠🖥️ Alhamza Al-Bayati 🔹Need for responsible AI regulation and oversight 🔹Early-alert fatigue leading to lower utilization 🔹Medicolegal implications of AI in healthcare @svinsociety
2
3
3
@SitaraKoneru
Sitara Koneru, MD
3 days
Incredible team effort planning this awesome meeting! Thank you to @esamaniego and his team for all their hard work #SVIN25 #SVIN25 @svinsociety @SVINJournal @YoungNIR @ESOstroke @MThrombectomy @WomenInNeuroIR @StrokeAHA_ASA @NguyenThanhMD @esamaniego @FazalZaidi9 @elghanemmoh
1
9
22
@neurona_critica
Mica Schachter, MD
3 days
#SVIN25 Session: Neurocritical Care After EVT: Welcome by Dr. Mayer
2
11
18
@romilsingh1892
Romil Singh MD (he/him)
3 days
Next up: Dr. Sam Zaidat @oozaidat on his journey with Intra-Saccular Diversion — taking aneurysm care inside the sac and from concept ➜ creation ➜ device reality. 🧠🔬 A look at how innovators reshape aneurysm treatment from the inside out. 💡🎯 #SVIN25 #NeuroIR
1
6
9
@romilsingh1892
Romil Singh MD (he/him)
3 days
🚫 Startups are not for the faint-hearted. 💡 But medical device startups let physicians impact more patients, solve unmet needs & transform care at scale. To build in MedTech you need: 🔁 Persistence 🔎 Optimism ⏳ Patience 🎯 Talent + Resources 💰 Funding 🕒 And to start early
0
5
3
@romilsingh1892
Romil Singh MD (he/him)
3 days
Now exploring how innovation is built, not born. @_AdnanSiddiqui shares the Buffalo model of creating an innovation ecosystem — where clinicians, engineers, industry & hospitals collaborate under one roof. 🧠🤝💡 From OR → lab → startup → impact. This is how ideas become
1
6
7
@catton_md
Raymond Catton, MD
3 days
Dural AVFs, anything new on the horizon? 🔹Utilization of combined arterial and venous 3D DSAs 🩻 🔹dAVF with transmedullary reflux presenting with cognitive impairment 🧠 🔹New generation of liquid embolics 🧪 🔹Differences between adult and pediatric dAVFs @svinsociety
3
4
3
@aemaz100
Muhammad Aemaz Ur Rehman
3 days
Dr @DavidAltschulMD walking us through cases where he should NOT have used an intrasaccular device. Real mistakes → real lessons → better decisions. 👀🧠 #SVIN25 @svinsociety @SVINJournal @YoungNIR @ESOstroke @MThrombectomy @esamaniego @FazalZaidi9 @elghanemmoh @GaborTothMD
1
7
7
@OmarAlJanabiMD
عُمَرْ ألجَنْابِي Omar Al-Janabi MD, MS, PhD
3 days
🧠🔥 Our NEXT session is Active Cerebrospinal Fluid Exchange ✨ vs Standard EVD for Intraventricular Hemorrhage drama🩸🧨 Interim Safety & Hematoma Clearance results from the DIVE Trial 🩸📉 Presented by Kimberly Agosto @YoungNIR @ESOstroke @MThrombectomy @WomenInNeuroIR
2
4
7